Answer extracted from The Single Source podcast — listen to the full episode below.
What maturity pressure currently affects the cannabis lending market?
The cannabis industry faces $5.4 billion in maturity obligations due within the next 24 months, but there is far insufficient capital available to meet these demands. This supply-demand imbalance creates a fundamentally different market structure for lenders, shifting power dynamics away from traditional competitive pressures.
A Credit Drought Reshapes Market Dynamics
The cannabis lending space currently suffers from severe capital scarcity relative to near-term debt obligations. As Brendan Fay explains in the episode, this creates an environment where lenders operate under fundamentally different conditions than in other private credit markets. Not only does the shortage of available capital compound the maturity pressure, but it also redistributes negotiating power decisively in the lender's favor.
The structural result is striking: lenders become price setters rather than price takers in this space. In most private credit industries, intense competition forces firms to accept whatever pricing the market dictates. Here, the opposite occurs. With so few capital providers relative to borrower demand, individual lenders gain pricing power that would be unimaginable in crowded markets.
This maturity wall stems partly from earlier financing rounds that assumed better regulatory and capital availability outcomes. As those obligations come due in concentrated waves, the mismatch between borrower needs and lender supply becomes acute. Coda Capital, the firm discussed in this podcast, has specifically built its strategy around limited license states—markets where cultivation, manufacturing, and retail licenses are restricted—precisely because these structural constraints create the defensibility that allows lenders to command better terms.
"Lenders in this space are going to be price setters rather than price takers, whereas in a lot of other private credit industries there's so much competition that private credit firms are price takers instead."
Brendan Fay — Founder and CIO, Coda Capital. Fay founded Coda Capital after a personal journey into medical cannabis, which helped transform his condition from rheumatoid arthritis. His partner brought vertically integrated cannabis operations spanning cultivation, manufacturing, and retail in Missouri, setting the foundation for Coda's differentiated approach to cannabis lending where scarcity of capital meets scarcity of licenses.
The deeper context reveals why this maturity pressure matters so acutely: as detailed in this conversation, many cannabis operators have historically been constrained by Section 280E tax treatment, which allowed the US government to claim up to 70% of operator profits before recent regulatory shifts. Operators refinancing those obligations now face tighter cash flows and less balance sheet capacity than lenders in other sectors might encounter. This compounds the urgency of finding capital providers willing to work constructively with borrowers under stress.
For investors and credit professionals watching the private credit landscape, this $5.4 billion maturity wall represents both a stress test and an opportunity. The question is not whether capital will be deployed into this space, but rather on whose terms—and whether it will be deployed efficiently or opportunistically.
See also
What investment focus does a private credit firm specializing in cannabis pursue to maximize competitive advantage?
Coda Capital focuses on limited license states in the cannabis industry where cultivation, manufacturing, and retail licenses are restricted, creating scarcity value and protections for operators in those markets.
How should global investors allocate to a high-conviction India strategy within a diversified portfolio?
Treat India allocation as a high-conviction alpha sleeve rather than India beta, as most global portfolios already have India exposure through EM funds or other vehicles.
What historical pattern has characterized India's performance relative to other emerging markets?
Historically, every time India has underperformed other emerging markets, that underperformance has reversed within 12 months, demonstrating consistent recovery patterns.
Key takeaways
- Cannabis operators face $5.4 billion in maturity obligations coming due within 24 months against severely insufficient capital availability.
- The capital shortage gives lenders unprecedented pricing power—they become price setters instead of price takers, reversing the typical private credit dynamic.
- Limited license states amplify this advantage by creating dual scarcity: restricted access to credit and restricted access to operating licenses.
- Operator cash flow constraints from historical Section 280E tax treatment further tighten refinancing capacity and borrower negotiating position.